arrow
S

Shui‐Ping Zhao

The Second Xiangya Hospital
H指数:41
被引数:6,198
浏览量:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

ApoA5-CIDEC axis regulates hepatic lipid metabolism, inflammation, and fibrosis in MASLD

ApoA5-CIDEC轴调节MASLD中的肝脂质代谢、炎症和纤维化。

2025-12-150
PRE
Efficacy and safety of ongericimab given by prefilled syringe or autoinjector in primary hypercholesterolemia and mixed hyperlipidemia
2024-09-011
PRE
Inhibition of Soluble Epoxide Hydrolase in Macrophages Ameliorates the Formation of Foam Cells - Role of Heme Oxygenase-1-
2019-11-254
OAAI
Niacin regulates apolipoprotein M expression via liver X receptor-α

烟酸通过肝X受体-α 调节载脂蛋白M的表达

2019-08-064
OAAI
Risk factors associated with atherogenic dyslipidemia in the presence of optimal statin therapy
2017-12-019
PREAI
Apolipoprotein A5 regulates intracellular triglyceride metabolism in adipocytes
2017-09-1120
OAAI
Magnitude of and gender differences in cardiovascular risk profiles among community residents in Shenzhen, China
2017-06-013
PREAI
Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet
2017-05-1930
OAAI
The genetic spectrum of familial hypercholesterolemia in the central south region of China
2017-03-0124
PREAI
Factors influencing low-density lipoprotein cholesterol target achievement in primary care - Results from DYSIS China
2016-11-012
PREAI
Efficacy and safety of fenofibrate as an add-on in patients with elevated triglyceride despite receiving statin treatment

尽管接受他汀类药物治疗,但非诺贝特作为甘油三酯升高患者的附加药物的疗效和安全性

2016-10-0117
PREAI